Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement

Abstract

The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting. (Int J Cardiovasc Intervent 2003; 5: 61-66)

• Carotid Stent
• Angioplasty
• Angioplasty
• Hyperperfusion